Companies → AGC INC.

Save to list

Remove

AGC INC.

Japan, Tokyo, Chiyoda-ku

Report a bug?

Claim ownership and edit

Description

AGC is a world-leading manufacturer of glass, chemicals, and high-tech materials. It has carved out one of the top share of the global market for automotive glass by establishing technology development sites in Japan, Europe, North America, and China that provide high-quality products, services, and solutions to global automobile manufacturers. The company's sells a range of products including architectural glass, automotive glass, glass substrates for displays, electronic materials, chlor-alkali & urethane, fluorochemicals & specialty chemicals, and life science products. Subsidiaries include US-based AGC America and AGC Glass Europe. Although the company is closely tied to the Japanese marketplace, it operates in more than 30 countries in Asia, Europe, and the Americas. The company was established in 1907 as Asahi Glass Co., Ltd. in Amagasaki, Hyogo Prefecture.

Industries

Glass and Glass Product Manufacturing; Other Miscellaneous Manufacturing; Nonmetallic Mineral Product Manufacturing; Manufacturing

SIC

Flat Glass; Manufacturing Industries, Nec; Stone, Clay, Glass, and Concrete Products; Manufacturing

Address:

1-5-1

MARUNOUCHI SHIN-MARUNOUCHI BLDG. 30F. -34F. CHIYODA-KU

TOKYO

100-0005 Japan

Website:

www.agc.com

Revenue

Recent news:

Is Corning a Strong Bet for Investors on Gorilla Glass Innovations?

GLW expands its Gorilla Glass lineup with Ceramic, a tougher glass-ceramic for phones, boosting appeal with Samsung and Motorola device makers.

Source: Zacks Dec 18, 2025

AGC’s Regenerative Medicine Partnership Might Change the Case for Investing in AGC (TSE:5201)

Celaid Therapeutics Inc. announced that it has entered a collaborative research agreement with AGC Inc. to advance iPS cell-derived hematopoietic stem and progenitor cells, aiming to address manufacturing challenges in cell therapy development. This partnership combines Celaid's proprietary stem cell technology with AGC's resources, marking a potential shift for AGC into the innovative field of regenerative medicine. We’ll now assess how AGC’s move into iPSC-based therapeutics could...

Source: Simply Wall St. Sep 8, 2025

TYO - Delayed Quote - USD

ASGLY

6.87 -0.19 (-2.69%)

At close March 23 06:00 UTC

Candle

Line

Financial Statistics

Valuation Measures

Current

Quarterly

As of 03/22/2026

Market Cap: 7.45 B

Enterprise Value: 10.95 B

Trailing P/E: 16.86

Forward P/E: N/A

PEG Ratio (5yr expected): N/A

Price/Sales (ttm): 0.57

Price/Book (mrq): 0.78

Enterprise Value/Revenue: 0.84

Enterprise Value/EBITDA: 5.40

Financial Highlights

Profitability and Income Statement

Profit Margin: 3.36%

Return on Assets (ttm): 2.75%

Return on Equity (ttm): 4.67%

Revenue (ttm): 2.06 T

Net Income Avi to Common (ttm): 69.16 B

Diluted EPS (ttm): 0.41

Balance Sheet and Cash Flow

Total Cash (mrq): 94.67 B

Total Debt/Equity (mrq): 37.33%

Levered Free Cash Flow (ttm): 80.28 B

Company is likely to buy

Company is likely to sell

Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.